BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7330812)

  • 1. Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.
    Bakker W; Nijhuis-Heddes JM; Wever AM; Brutel de la Rivière A; van der Velde EA; Dijkman JH
    Thorax; 1981 Nov; 36(11):870-4. PubMed ID: 7330812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.
    Bakker W; Nijhuis-Heddes JM; van der Velde EA
    Cancer Immunol Immunother; 1986; 22(2):155-9. PubMed ID: 3719595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapleural BCG in operable lung cancer.
    Lowe J; Iles PB; Shore DF; Langman MJ; Baldwin RW
    Lancet; 1980 Jan; 1(8158):11-4. PubMed ID: 6101353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
    Jansen HM; The TH; Orie NG
    Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):649-57. PubMed ID: 7029149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional immunotherapy of lung cancer with intrapleural B.C.G.
    McKneally MF; Maver C; Kausel HW
    Lancet; 1976 Feb; 1(7956):377-9. PubMed ID: 55646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.
    Gail MH
    Chest; 1994 Dec; 106(6 Suppl):287S-292S. PubMed ID: 7988246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
    Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
    Yamamura Y; Sakatani M; Ogura T; Azuma I
    Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
    Warren SE; Crispen RG; Nika B
    Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.
    Roeslin N; Lang JM; Morand G; Wihlm JM; Witz JP
    Cancer Immunol Immunother; 1982; 13(3):174-5. PubMed ID: 6925982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
    Morishita M
    Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized trial of adjuvant BCG immunotherapy in head and neck cancer.
    Taylor SG; Sisson GA; Bytell DE; Raynor WJ
    Arch Otolaryngol; 1983 Aug; 109(8):544-9. PubMed ID: 6347154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
    Holmäng S; Ströck V
    Eur Urol; 2012 Mar; 61(3):503-7. PubMed ID: 22119022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery, BCG immunotherapy, and multichemotherapy in T3 stage-3 bronchogenic carcinoma.
    Rioseco A
    Chest; 1981 Feb; 79(2):176-85. PubMed ID: 7460649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer.
    Stack BH; McSwan N; Stirling JM; Hole DJ; Spilg WG; McHattie I; Elliott JA; Gillis CR; Turner MA; White RG
    Thorax; 1982 Aug; 37(8):588-93. PubMed ID: 7179188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG immunostimulation in primary pulmonary cancer (a clinical, immunological and radiological study).
    Dénes L; Büttner K; Galambos G; Krasznai G
    Dev Biol Stand; 1986; 58 ( Pt A)():425-32. PubMed ID: 3297874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.